The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma
about
Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasetsHypoxia and cell cycle regulation of the von Hippel-Lindau tumor suppressorThe solution structure of the ZnF UBP domain of USP33/VDU1State of the science: an update on renal cell carcinomaCritical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic StressThe role of hypoxia in orthodontic tooth movementPredictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinomaSunitinib in the treatment of metastatic renal cell carcinomaHIF-2α/ITPR1 axis: A new saboteur of NK-mediated lysisSunitinib in solid tumorsELR510444 inhibits tumor growth and angiogenesis by abrogating HIF activity and disrupting microtubules in renal cell carcinomaThe sonic hedgehog signaling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth.Hypoxia-inducible factor-1 as a therapeutic target in endometrial cancer managementThe lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1Development of HIF-1 inhibitors for cancer therapyExpression of von Hippel-Lindau tumor suppressor protein (pVHL) characteristic of tongue cancer and proliferative lesions in tongue epitheliumBirt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.Serum level and immunohistochemical expression of vascular endothelial growth factor for the prediction of postoperative recurrence in renal cell carcinoma.Vascular endothelial growth factor-related pathways in hemato-lymphoid malignancies.Increased Nek1 expression in renal cell carcinoma cells is associated with decreased sensitivity to DNA-damaging treatmentComparative analysis of novel and conventional Hsp90 inhibitors on HIF activity and angiogenic potential in clear cell renal cell carcinoma: implications for clinical evaluationLIM-class homeobox gene Lim1, a novel oncogene in human renal cell carcinoma.Genitourinary oncology: current status and future challenges.The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma.Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors.VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKC{delta}-driven migrationTargeted therapies in the management of renal cell carcinoma: role of bevacizumabDifferential genetic expression in large versus small clear cell renal cell carcinoma: results from microarray analysisMDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.Germline and somatic DNA methylation and epigenetic regulation of KILLIN in renal cell carcinoma.Biology of metastatic renal cell carcinoma.Critical appraisal of pazopanib as treatment for patients with advanced metastatic renal cell carcinomaRenal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling.Biomarkers in tumor angiogenesis and anti-angiogenic therapy.Genome-Wide Profiling of TRACK Kidneys Shows Similarity to the Human ccRCC Transcriptome.Phospholipase D: enzymology, functionality, and chemical modulationTargeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma.Familial renal cancer: molecular genetics and surgical management.Genome-wide mapping of Hif-1α binding sites in zebrafishIdentification and functional characterization of pVHL-dependent cell surface proteins in renal cell carcinoma.
P2860
Q21183974-A46CB828-1ED7-4189-8D39-19A4067B8BAFQ24298032-E2C53600-D981-4193-8FC7-7E4BA4C0F7CCQ24338879-195FA0D1-EB11-488D-96BD-2693DDF666BFQ24630685-4487A264-9E07-4306-9FCB-D5F8A6FF2A3EQ26781260-454EA028-DB36-4F69-9669-D66CC155A954Q27027959-B6D54440-FDF5-4EE4-920F-4A1D5FFD8411Q28067482-D54BFCFD-9847-426A-8494-1DD63AAA0EC1Q28072057-25402392-0B6E-4938-AC68-218427FE348DQ28080547-DBFE9DB8-5ECF-4629-8BE2-8AD731B3F490Q28245467-726B433A-F403-453D-88EA-94FBB2A0330CQ28479196-ABB12CC5-754E-444F-9700-6B03558F57D9Q33578572-0A7B7941-EB34-4DEE-B1A1-40E23A8BFFC1Q33652379-BD59E936-F1C9-4195-AC9F-4212270ADD83Q33673803-0C6FA816-028A-4C33-A06A-B06FB191D0B1Q33703381-AC6EAF84-AC54-49E3-ACB2-5FD66631BE37Q33733536-7F6AADE4-E4D2-46BC-834E-95B128EF06ECQ33772820-8D06E2E6-89C9-44F7-BD44-F43AA049A2B2Q33811628-448481CD-BC70-4999-9991-2F1109094C72Q33874179-C7FF530E-3F76-4C42-ABE3-6D83201AD90FQ34100935-5943B910-C3BF-477E-B776-87E250A6E7BBQ34102029-0FFBFF91-24F2-4047-B7D6-1A87C4734379Q34153409-2B8D0D97-5590-4D40-BA96-66065BC6AAC6Q34278266-34A22AB7-A158-4F19-AADF-6835EE29EA1FQ34365135-04CC1769-1A4E-4BFD-9F02-F6E899686114Q34382527-F1AA81FA-CDA5-4963-AFC5-05E04AF47A75Q34549885-26BF04BA-BB77-4B59-AAA5-8B44B707C52FQ34611205-5EB08345-6E56-475C-9A25-DE4FA0A9BA52Q35001559-2AB4B312-E942-4F3E-8926-E3BE28CC2C6FQ35028389-34D9C4BD-EB2D-48D5-8228-5857D14255C3Q35032574-BE4EB666-1297-482F-A242-E6DFB396BB80Q35167463-1DFD486F-5A12-4CEB-8458-DE1E5C734808Q35212949-9002583C-A15B-4CCE-A40B-CD9E8B13A65BQ35456356-9F95CF02-C66A-4C13-A4A2-5E43DF847C9EQ35536088-6CB60A07-B695-4068-8D15-438D12A9CF23Q35567752-5D41E886-0A36-43C3-A286-AEEB0FF5B91EQ35599714-8DE68FF0-C0F8-49C1-A203-578EF6EBA529Q35623092-8EDFF8B7-B87A-41EA-9DDB-B68EEB2A18CDQ35687676-7B2771AB-091E-4F03-AE07-4542F616CD9DQ35838967-B66EB1D2-C432-495C-B18D-7EA10AFA11E4Q36088193-D05C2557-BFF4-46C3-8493-A99E983F4D22
P2860
The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma
@ast
The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma
@en
The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma
@nl
type
label
The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma
@ast
The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma
@en
The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma
@nl
prefLabel
The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma
@ast
The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma
@en
The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma
@nl
P3181
P1476
The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma
@en
P304
P3181
P356
10.1158/1078-0432.CCR-06-1865
P407
P433
P577
2007-01-15T00:00:00Z